Clinical trials by pharmaceutical companies deliver value to the Danish society. On average, a clinical trial improves GDP by DKK 0.9m and the public budget by DKK 1.2m.

The positive economic effects arise from trials conducted in Denmark through several drivers; by contributing to more and better healthcare, by creating highly productive jobs and by propelling new research in Life Sciences. In 2015 alone, pharmaceutical companies paid out DKK 248m to the public Danish healthcare system as part of their clinical trials.

Learn more about the study
For further information, please contact Christian Jervelund